Company news
Valirx Plc (LSE:VAL) news
Valirx Plc news releases on 6ix. Latest, May 18, 2016: Conversion of Loan Note, issue of warrant & equity
Press releases — page 6
Conversion of Loan Note, issue of warrant & equity
May 18, 2016
Notification of US Patent Grant for VAL401
April 29, 2016
ValiRx to exhibit at the UK Investor Show
April 22, 2016
Issue of Equity - conversion of loan note
April 19, 2016
ValiRx to exhibit and present at the AACR
March 31, 2016
Convertible Loan Facility of up to £4.0 million
March 21, 2016
ValiRx engages US investor relations firm
March 17, 2016
Placing to raise £0.5 million
February 17, 2016
Quarterly Update on Clinical Progress
February 9, 2016
ValiRx to present at Shares Investor Meeting
December 11, 2015
Clinical Phase Development Update
November 19, 2015
ValiRx establishes US office in Boston, MA
November 5, 2015
Collaboration Agreement
October 27, 2015
New Japanese Patent Grant
October 1, 2015
Half Yearly Report
September 17, 2015
Subscription and Equity Swap
September 16, 2015
Collaboration and Research Studentship Agreement
August 6, 2015
Grant of options
June 29, 2015
UPDATE on VAL201 Clinical Trial
June 25, 2015
Change of Adviser
June 3, 2015
Stmnt re Share Price Movement
May 27, 2015
Result of AGM and Capital Reorganisation
May 15, 2015
Notification of US Patent Grant Allowance reVAL401
May 14, 2015
Re Contract
May 7, 2015
ValiRX to attend 2015 BIO International Convention
April 30, 2015
Notice of AGM and Proposed Capital Reorganisation
April 22, 2015
Issue of equity to Cancer Research Technology Ltd
March 17, 2015
Placing to raise GBP800,000
March 6, 2015
New Endometriosis Patent Grant
February 26, 2015
Successful 1st Results from VAL201 Clinical Trial
February 24, 2015
New European Patent Grant
February 11, 2015
Acquisition
February 5, 2015
Clinical Trial and Development Update
January 15, 2015
ValiSeek Scientific Update
December 4, 2014
Re: Progress with Trial Recruitment and Testing
November 26, 2014
Approved Clinical Trial Update
November 3, 2014
Early Completion of Equity Swap Agreement
October 8, 2014
ValiSeek Development Update
September 2, 2014
Notice of Acceptance of CTA Request
August 4, 2014
New Corporate Website & New Office Address
June 18, 2014
Submission of Clinical Trial Application re VAL201
June 10, 2014
ValiSeek Joint Venture
April 8, 2014
Posting of R&As and Notice of AGM
March 28, 2014
Sale of shares in VolitionRx
January 31, 2014
Grant of Options
January 22, 2014
Fundraising and Equity Swap
December 27, 2013
New Australian Patent Grant
December 5, 2013
Update re Positive VAL201 & Biomarker Unit Studies
November 28, 2013
Placing to raise ?1m
November 15, 2013
Re: VAL201 - Update
October 24, 2013